G. N. Smykova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
G. N. Smykova has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- A. S. Todorova
Rostov State Medical University (Research Institute of Obstetrics and Pediatrics)
1 shared publication - Alexander Anatolyevich Lebedenko
Rostov State Medical University
1 shared publication - E. A. Lukyanova
Rostov State Medical University (Research Institute of Obstetrics and Pediatrics)
1 shared publication - E. A. Papsheva
Rostov State Medical University (Research Institute of Obstetrics and Pediatrics)
1 shared publication - E. Y. Kaushanskay
Rostov State Medical University (Research Institute of Obstetrics and Pediatrics)
1 shared publication - L. N. Taranenko
Rostov State Medical University (Research Institute of Obstetrics and Pediatrics)
1 shared publication
Latest Publications
- Open Access
- 20 December 2020
- Published by Rostov State Medical University in Medical Herald of the South of Russia
- Vol. 11 (4) , 84-91
A rare case of type i glutaric aciduria in an early child
Glutaric aciduria type I (deficiency of glutaryl-COA dehydrogenase, glutaric acidemia type I) is a rare autosomal recessive disease caused by mutations in the gene encoding the enzyme glutaryl – COA - dehydrogenase (GCDH). Cerebral organic aciduria, caused by a deficiency of glutaryl-COA - dehydrogenase, is generally considered a neurological disorder.The phenotypic spectrum of untreated GA-1 varies from a more common and pronounced form (a disease with infancy) to a low-symptom and less common form. In people with the same genotype, the clinical manifestations and depth of CNS damage can vary widely depending on the age of manifestation of acute encephalopathic crises. It is assumed that with early detection and treatment of “asymptomatic” newborns (in the context of screening for this disease), most people who would have developed manifestations of GA-1 with childhood or late onset will remain asymptomatic.
- 20 December 2020
- Published by Rostov State Medical University in Medical Herald of the South of Russia
- Vol. 11 (4) , 84-91
Open AccessA rare case of type i glutaric aciduria in an early child
Glutaric aciduria type I (deficiency of glutaryl-COA dehydrogenase, glutaric acidemia type I) is a rare autosomal recessive disease caused by mutations in the gene encoding the enzyme glutaryl – COA - dehydrogenase (GCDH). Cerebral organic aciduria, caused by a deficiency of glutaryl-COA - dehydrogenase, is generally considered a neurological disorder.The phenotypic spectrum of untreated GA-1 varies from a more common and pronounced form (a disease with infancy) to a low-symptom and less common form. In people with the same genotype, the clinical manifestations and depth of CNS damage can vary widely depending on the age of manifestation of acute encephalopathic crises. It is assumed that with early detection and treatment of “asymptomatic” newborns (in the context of screening for this disease), most people who would have developed manifestations of GA-1 with childhood or late onset will remain asymptomatic.